{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:04:12Z","timestamp":1793419452842,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bcp.2021.114546","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T01:52:03Z","timestamp":1617846723000},"page":"114546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma"],"prefix":"10.1016","volume":"188","author":[{"given":"Yingying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lushan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2021.114546_b0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bcp.2021.114546_b0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jjco\/hyx180","article-title":"Chemotherapy for hepatocellular carcinoma: current status and future perspectives","volume":"48","author":"Ikeda","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114546_b0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"issue":"10","key":"10.1016\/j.bcp.2021.114546_b0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/1389200219666180529113818","article-title":"Failure of chemotherapy in hepatocellular carcinoma due to impaired and dysregulated primary liver drug metabolizing enzymes and drug transport proteins: what to do?","volume":"19","author":"Ul-Islam","year":"2018","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"10.1016\/j.bcp.2021.114546_b0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/bph.14563","article-title":"Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib","volume":"176","author":"Al-Abdulla","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114546_b0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/dmd.116.072264","article-title":"Organic anion transporter 2: an enigmatic human solute carrier","volume":"45","author":"Shen","year":"2017","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.bcp.2021.114546_b0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1211\/0022357055966","article-title":"Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7])","volume":"57","author":"Kobayashi","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114546_b0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.phrs.2014.11.002","article-title":"Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs","volume":"91","author":"Marada","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114546_b0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jchromb.2007.09.039","article-title":"Development and characterization of immobilized human organic anion transporter-based liquid chromatographic stationary phase: hOAT1 and hOAT2","volume":"859","author":"Kimura","year":"2007","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.bcp.2021.114546_b0050","first-page":"528","article-title":"High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX-based chemotherapy","volume":"4","author":"Tashiro","year":"2014","journal-title":"Am. J. Cancer Res."},{"issue":"D1","key":"10.1016\/j.bcp.2021.114546_b0055","doi-asserted-by":"crossref","first-page":"D1042","DOI":"10.1093\/nar\/gkz779","article-title":"VARIDT 1.0: variability of drug transporter database","volume":"48","author":"Yin","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114546_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hepr.13250","article-title":"Epigenetic dysregulation in hepatocellular carcinoma: an up-to-date review","volume":"49","author":"Nakamura","year":"2019","journal-title":"Hepatol. Res."},{"issue":"12","key":"10.1016\/j.bcp.2021.114546_b0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/gm298","article-title":"DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma","volume":"3","author":"Schaeffeler","year":"2011","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.bcp.2021.114546_b0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11095-010-0064-3","article-title":"DNA methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines","volume":"27","author":"Ichihara","year":"2010","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.bcp.2021.114546_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076474","article-title":"Different involvement of promoter methylation in the expression of organic cation\/carnitine transporter 2 (OCTN2) in cancer cell lines","volume":"8","author":"Qu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcp.2021.114546_b0080","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bcp.2015.09.020","article-title":"Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells","volume":"98","author":"Yu","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"348","key":"10.1016\/j.bcp.2021.114546_b0085","doi-asserted-by":"crossref","first-page":"348ra97","DOI":"10.1126\/scitranslmed.aaf3124","article-title":"Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin","volume":"8","author":"Liu","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.bcp.2021.114546_b0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/15592294.2019.1615354","article-title":"Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma","volume":"14","author":"Zhu","year":"2019","journal-title":"Epigenetics"},{"issue":"22","key":"10.1016\/j.bcp.2021.114546_b0095","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1111\/bph.14467","article-title":"Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state","volume":"175","author":"Ye","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114546_b0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4132\/jptm.2016.05.20","article-title":"SIRT7, H3K18ac, and ELK4 immunohistochemical expression in hepatocellular carcinoma","volume":"50","author":"Lee","year":"2016","journal-title":"J. Pathol. Transl. Med."},{"issue":"5","key":"10.1016\/j.bcp.2021.114546_b0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nsmb.3202","article-title":"SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence","volume":"23","author":"Tasselli","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114546_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/EBC20180061","article-title":"Acetylation & Co: an expanding repertoire of histone acylations regulates chromatin and transcription","volume":"63","author":"Barnes","year":"2019","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bcp.2021.114546_b0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2019.05.078","article-title":"Histone acetyltransferase inhibitors: an overview in synthesis, structure-activity relationship and molecular mechanism","volume":"178","author":"Huang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2021.114546_b0120","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7150\/ijbs.17260","article-title":"Acetylation of hMOF modulates H4K16ac to regulate DNA repair genes in response to oxidative stress","volume":"13","author":"Zhong","year":"2017","journal-title":"Int. J. Biol. Sci."},{"issue":"15","key":"10.1016\/j.bcp.2021.114546_b0125","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1111\/febs.12863","article-title":"MDM2-MOF-H4K16ac axis contributes to tumorigenesis induced by Notch","volume":"281","author":"Liu","year":"2014","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114546_b0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/BJ20101904","article-title":"OAT2 catalyses efflux of glutamate and uptake of orotic acid","volume":"436","author":"Fork","year":"2011","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bcp.2021.114546_b0135","doi-asserted-by":"crossref","first-page":"F361","DOI":"10.1152\/ajprenal.00207.2006","article-title":"Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones","volume":"292","author":"Ljubojevic","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114546_b0140","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1124\/dmd.106.010033","article-title":"Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes","volume":"34","author":"Jigorel","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.bcp.2021.114546_b0145","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bcp.2006.03.016","article-title":"Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha","volume":"72","author":"Maher","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114546_b0150","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1124\/mol.104.010223","article-title":"The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4 alpha and suppressed by bile acids","volume":"67","author":"Popowski","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114546_b0155","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.93.12.5705","article-title":"Second generation hybrid polar compounds are potent inducers of transformed cell differentiation","volume":"93","author":"Richon","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2021.114546_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-230X(02)86002-X","article-title":"Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation","volume":"86","author":"Lehrmann","year":"2002","journal-title":"Adv. Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114546_b0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/21541264.2016.1276658","article-title":"The seven faces of SIRT7","volume":"8","author":"Blank","year":"2017","journal-title":"Transcription"},{"issue":"5","key":"10.1016\/j.bcp.2021.114546_b0170","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.apsb.2019.01.002","article-title":"Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2","volume":"9","author":"Chen","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.bcp.2021.114546_b0175","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1080\/15476286.2019.1602436","article-title":"A novel human lncRNA SANT1 cis-regulates the expression of SLC47A2 by altering SFPQ\/E2F1\/HDAC1 binding to the promoter region in renal cell carcinoma","volume":"16","author":"Gao","year":"2019","journal-title":"RNA Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114546_b0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000356643","article-title":"Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study","volume":"86","author":"Yasui","year":"2014","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.bcp.2021.114546_b0185","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00535-013-0791-4","article-title":"Mitochondrial metabolism in the noncancerous liver determine the occurrence of hepatocellular carcinoma: a prospective study","volume":"49","author":"Kudo","year":"2014","journal-title":"J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114546_b0190","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.7314\/APJCP.2012.13.9.4807","article-title":"Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line","volume":"13","author":"Gu","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.bcp.2021.114546_b0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccell.2016.08.001","article-title":"Feedback activation of leukemia inhibitory factor receptor limits response to histone deacetylase inhibitors in breast cancer","volume":"30","author":"Zeng","year":"2016","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.bcp.2021.114546_b0200","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3390\/cancers12123527","article-title":"SAHA overcomes 5-FU resistance in IFIT2-depleted oral squamous cell carcinoma cells","volume":"12","author":"Regmi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.bcp.2021.114546_b0205","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1007\/s13277-015-3497-9","article-title":"Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase","volume":"36","author":"Liao","year":"2015","journal-title":"Tumour Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221001428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221001428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:26:52Z","timestamp":1757770012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221001428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":41,"alternative-id":["S0006295221001428"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114546","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114546"}}